Owner Archemix Corp.

Inventors Lagasse, Daniel H. A.; Diener, John L.

Agent Cullens

Pub. Number AU-B-2005287273

PCT Pub. Number WO2006/033854

Priority 60/608,047 07.09.04 US; 60/678,427 06.05.05 US; 60/661,950 11.03.05 US; 60/690,231 13.06.05 US

Filing date 7 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 12 May 2011

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/115 (2010.01) Mutation or genetic engineering - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith

C12N 15/88 (2006.01) Mutation or genetic engineering

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids